CA2100268A1 - Method for culturing and transforming human stem cell-containing compositions - Google Patents
Method for culturing and transforming human stem cell-containing compositionsInfo
- Publication number
- CA2100268A1 CA2100268A1 CA002100268A CA2100268A CA2100268A1 CA 2100268 A1 CA2100268 A1 CA 2100268A1 CA 002100268 A CA002100268 A CA 002100268A CA 2100268 A CA2100268 A CA 2100268A CA 2100268 A1 CA2100268 A1 CA 2100268A1
- Authority
- CA
- Canada
- Prior art keywords
- human
- culture
- culturing
- human stem
- stem cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5403—IL-3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/34—Internal compartments or partitions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/08—Chemical, biochemical or biological means, e.g. plasma jet, co-culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/14—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Abstract
Methods, including culture media conditions and reactors, which provide for ex vivo human stem cell division and stable genetic transformation and/or the optimization of human hematopoietic progenitor cell cultures and/or increasing the metabolism or GM-CSF secretion or IL-6 secretion of human stromal cells are disclosed.
The methods rely on culturing human stem cells and/or human hemapoietic progenitor cells and/or human stromal cells in a liquid culture medium which is replaced, preferably perfused, either continuously or periodically, at a rate of 1 ml of medium per ml of culture per about 24 to about 48 hour period, and removing metabolic products and replenishing depleted nutrients while maintaining the culture under physiologically acceptable conditions. Optionally growth factors are added to the culture medium.
The methods rely on culturing human stem cells and/or human hemapoietic progenitor cells and/or human stromal cells in a liquid culture medium which is replaced, preferably perfused, either continuously or periodically, at a rate of 1 ml of medium per ml of culture per about 24 to about 48 hour period, and removing metabolic products and replenishing depleted nutrients while maintaining the culture under physiologically acceptable conditions. Optionally growth factors are added to the culture medium.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62834390A | 1990-12-17 | 1990-12-17 | |
US628,343 | 1990-12-17 | ||
US73702491A | 1991-07-29 | 1991-07-29 | |
US737,024 | 1991-07-29 | ||
US740,590 | 1991-08-05 | ||
US07/740,590 US5399493A (en) | 1989-06-15 | 1991-08-05 | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
PCT/US1991/009173 WO1992011355A1 (en) | 1990-12-17 | 1991-12-17 | Method for culturing and transforming human stem cell-containing compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2100268A1 true CA2100268A1 (en) | 1992-06-18 |
CA2100268C CA2100268C (en) | 2008-12-02 |
Family
ID=27417447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002100268A Expired - Lifetime CA2100268C (en) | 1990-12-17 | 1991-12-17 | Method for culturing and transforming human stem cell-containing compositions |
Country Status (9)
Country | Link |
---|---|
US (2) | US5399493A (en) |
EP (2) | EP1473360A3 (en) |
JP (5) | JPH06505151A (en) |
KR (1) | KR100225307B1 (en) |
AT (1) | ATE295412T1 (en) |
AU (1) | AU687674B2 (en) |
CA (1) | CA2100268C (en) |
DE (1) | DE69133459T2 (en) |
WO (1) | WO1992011355A1 (en) |
Families Citing this family (192)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2060942T3 (en) * | 1989-02-02 | 1994-12-01 | Joel S Greenberger | GENETIC THERAPY USING STROMIC CELLS. |
US5635386A (en) * | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5635387A (en) * | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
EP0535148B1 (en) * | 1990-06-08 | 1998-03-18 | New York University | Stimulation of bone marrow stromal and progenitor cells |
US20030125519A1 (en) | 1990-08-27 | 2003-07-03 | Peter Besmer | Ligand for the c-kit receptor and methods of use thereof |
US5744361A (en) * | 1991-04-09 | 1998-04-28 | Indiana University | Expansion of human hematopoietic progenitor cells in a liquid medium |
US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
NL9101680A (en) * | 1991-10-04 | 1993-05-03 | Tno | METHOD FOR GENETICALLY MODIFYING PRIMATE BONE MARROW CELLS AND USE CELLS PRODUCING RECOMBINANT RETROVIRAL VECTORS. |
DE69332374T2 (en) * | 1992-03-04 | 2003-06-12 | Univ Michigan Ann Arbor | METHOD, COMPOSITIONS AND DEVICES FOR THE PRESERVATION AND BREEDING OF HUMAN STEM CELLS AND / OR HEMATOPOETIC CELLS |
WO1993018648A1 (en) * | 1992-03-23 | 1993-09-30 | Baxter International Inc. | In vitro-derived human neutrophil precursor cells |
US6001803A (en) * | 1992-04-23 | 1999-12-14 | Sloan-Kettering Institute For Cancer Research | Composition of c-kit ligand, GM-CSF, and TNF-α and method of use |
PT639979E (en) * | 1992-04-23 | 2002-03-28 | Sloan Kettering Inst Cancer | CONNECTING TO THE C-KIT RECEIVER AND METHODS FOR YOUR USE |
GB9308271D0 (en) | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
NZ314644A (en) | 1993-05-24 | 2000-11-24 | Immunex Corp | Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue |
US5554512A (en) * | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
US6037174A (en) * | 1993-08-23 | 2000-03-14 | Nexell Therapeutics, Inc. | Preparation of serum-free suspensions of human hematopoietic cells or precursor cells |
US5846529A (en) * | 1993-08-23 | 1998-12-08 | Nexell Therapeutics, Inc. | Infusion of neutrophil precursors for treatment of neutropenia |
FR2709309B1 (en) * | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Cellular compositions, preparation and therapeutic uses. |
US5534423A (en) * | 1993-10-08 | 1996-07-09 | Regents Of The University Of Michigan | Methods of increasing rates of infection by directing motion of vectors |
US5599705A (en) * | 1993-11-16 | 1997-02-04 | Cameron; Robert B. | In vitro method for producing differentiated universally compatible mature human blood cells |
US6190655B1 (en) | 1993-12-03 | 2001-02-20 | Immunex Corporation | Methods of using Flt-3 ligand for exogenous gene transfer |
JPH09511392A (en) * | 1994-02-09 | 1997-11-18 | ユニシン・テクノロジーズ・インコーポレーテッド | High performance cell culture bioreactor and method |
US5882918A (en) * | 1995-08-08 | 1999-03-16 | Genespan Corporation | Cell culture incubator |
US5622857A (en) * | 1995-08-08 | 1997-04-22 | Genespan Corporation | High performance cell culture bioreactor and method |
US7294331B2 (en) * | 1994-03-07 | 2007-11-13 | Immunex Corporation | Methods of using flt3-ligand in hematopoietic cell transplantation |
US6242417B1 (en) | 1994-03-08 | 2001-06-05 | Somatogen, Inc. | Stabilized compositions containing hemoglobin |
US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
WO1995024464A1 (en) * | 1994-03-11 | 1995-09-14 | Baxter International Inc. | Flow-through bioreactor with grooves for cell retention |
US5512480A (en) * | 1994-03-11 | 1996-04-30 | Baxter International Inc. | Flow-through bioreactor with grooves for cell retention |
US7083979B1 (en) * | 1994-03-25 | 2006-08-01 | Indiana University Foundation | Methods for enhanced retroviral-mediated gene transfer |
DE4422667A1 (en) * | 1994-06-30 | 1996-01-04 | Boehringer Ingelheim Int | Process for the production and cultivation of hematopoietic progenitor cells |
US5811274A (en) * | 1994-12-09 | 1998-09-22 | The Regents Of The University Of Michigan | Methods, compositions and apparatus for cell transfection |
WO1996017627A2 (en) * | 1994-12-09 | 1996-06-13 | Mosca Joseph D | System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |
FR2728584A1 (en) * | 1994-12-22 | 1996-06-28 | Centre Nat Rech Scient | METHOD OF GENE TRANSFER INTO ACTIVATED CELLS FROM A REST STATE |
US6974571B2 (en) * | 1995-03-28 | 2005-12-13 | Thomas Jefferson University | Isolated stromal cells and methods of using the same |
US5719058A (en) * | 1995-04-10 | 1998-02-17 | Merck & Co., Inc. | Method for producing a highly enriched population of osteoclast cells |
US5846828A (en) * | 1995-06-07 | 1998-12-08 | Advanced Tissue Sciences | Apparatus and method for sterilizing, seeding, culturing, storing, shipping, and testing tissue, synthetic, or mechanical heart valves orvalve segments |
US6121042A (en) * | 1995-04-27 | 2000-09-19 | Advanced Tissue Sciences, Inc. | Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs |
US5792603A (en) * | 1995-04-27 | 1998-08-11 | Advanced Tissue Sciences, Inc. | Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts |
US5876956A (en) * | 1995-05-15 | 1999-03-02 | Johns Hopkins University School Of Medicine | Methods for identification or purification of cells containing an enzymatic intracellular marker |
US5925567A (en) * | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
US5674750A (en) * | 1995-05-19 | 1997-10-07 | T. Breeders | Continuous selective clonogenic expansion of relatively undifferentiated cells |
US5843766A (en) * | 1995-06-07 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Apparatus for the growth and packaging of three dimensional tissue cultures |
US5688687A (en) * | 1995-06-07 | 1997-11-18 | Aastrom Biosciences, Inc. | Bioreactor for mammalian cell growth and maintenance |
AU5931896A (en) * | 1995-06-07 | 1996-12-30 | Advanced Tissue Sciences, Inc. | Apparatus and method for sterilizing, seeding, culturing, st oring, shipping, and testing replacement cartilage tissue co nstructs |
US5728581A (en) * | 1995-06-07 | 1998-03-17 | Systemix, Inc. | Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US20020034517A1 (en) * | 1995-10-04 | 2002-03-21 | Kenneth Brasel | Dendritic cell stimulatory factor |
US7361330B2 (en) * | 1995-10-04 | 2008-04-22 | Immunex Corporation | Methods of using flt3-ligand in the treatment of fibrosarcoma |
US7150992B1 (en) | 1995-10-04 | 2006-12-19 | Innunex Corporation | Methods of preparing dendritic cells with flt3-ligand and antigen |
US6060052A (en) | 1995-10-30 | 2000-05-09 | Systemix, Inc. | Methods for use of Mpl ligands with primitive human hematopoietic stem cells |
US5766950A (en) * | 1995-12-29 | 1998-06-16 | Alg Company | Expansion of bone marrow stromal cells |
US6991787B1 (en) | 1995-12-29 | 2006-01-31 | Alg Company | Methods of preparing bone marrow stromal cells for use in gene therapy |
US5763267A (en) * | 1996-04-16 | 1998-06-09 | Advanced Tissue Sciences | Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures |
US6165785A (en) * | 1996-05-24 | 2000-12-26 | University Of Cincinnati | Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications |
US6383480B1 (en) * | 1996-07-10 | 2002-05-07 | Meiji Milk Products, Co., Ltd. | Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells |
US6458585B1 (en) | 1996-08-14 | 2002-10-01 | Nexell Therapeutics Inc. | Cytokine-free culture of dendritic cells |
DE69723531T3 (en) | 1996-10-01 | 2012-09-06 | Geron Corp. | Catalytic subunit of human telomerase |
US6331406B1 (en) * | 1997-03-31 | 2001-12-18 | The John Hopkins University School Of Medicine | Human enbryonic germ cell and methods of use |
US6090622A (en) * | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
AU7481098A (en) * | 1997-05-13 | 1998-12-08 | Case Western Reserve University | Osteoarthritis cartilage regeneration using human mesenchymal stem ce lls |
US20020034819A1 (en) * | 1998-02-23 | 2002-03-21 | Alan K. Smith | Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses |
US6835377B2 (en) | 1998-05-13 | 2004-12-28 | Osiris Therapeutics, Inc. | Osteoarthritis cartilage regeneration |
CA2330190C (en) * | 1998-06-08 | 2009-12-22 | Osiris Therapeutics, Inc. | Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
AUPP421298A0 (en) * | 1998-06-19 | 1998-07-09 | Fertilitescentrum Ab | Method and medium for in vitro culture of human embryos |
JP2002523039A (en) * | 1998-08-24 | 2002-07-30 | ティー.ブリーダーズ,インコーポレイテッド | Cell population containing non-fetal hemangioblasts and method for producing the same |
GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
US20040241842A1 (en) * | 1999-04-15 | 2004-12-02 | Monash University | Stimulation of thymus for vaccination development |
US20040265285A1 (en) * | 1999-04-15 | 2004-12-30 | Monash University | Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
AUPR074500A0 (en) * | 2000-10-13 | 2000-11-09 | Monash University | Treatment of t cell disorders |
US20040259803A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Disease prevention by reactivation of the thymus |
US20070274946A1 (en) * | 1999-04-15 | 2007-11-29 | Norwood Immunoloty, Ltd. | Tolerance to Graft Prior to Thymic Reactivation |
US20040258672A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Graft acceptance through manipulation of thymic regeneration |
US20050020524A1 (en) * | 1999-04-15 | 2005-01-27 | Monash University | Hematopoietic stem cell gene therapy |
WO2001023528A1 (en) * | 1999-09-27 | 2001-04-05 | University Of Florida Research Foundation | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
CA2393252A1 (en) * | 1999-12-06 | 2001-06-07 | Paul Calabresi | Use of methylol-containing compounds to treat tumors |
US6682902B2 (en) | 1999-12-16 | 2004-01-27 | Schering Aktiengesellschaft | DNA encoding a novel RG1 polypeptide |
DE60143517D1 (en) * | 2000-04-25 | 2011-01-05 | Osiris Therapeutics Inc | RESTORING THE RACES WITH MESENCHYMAL STEM CELLS |
US6828145B2 (en) | 2000-05-10 | 2004-12-07 | Cedars-Sinai Medical Center | Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker |
NL1017973C2 (en) * | 2000-05-10 | 2002-11-08 | Tristem Trading Cyprus Ltd | Design. |
EP1167517A1 (en) * | 2000-06-22 | 2002-01-02 | IsoTis N.V. | Tissue engineering |
JP2004506414A (en) * | 2000-06-28 | 2004-03-04 | アセンデイア アクチエボラグ | DNA / RNA integration media and methods of use |
US20060088512A1 (en) * | 2001-10-15 | 2006-04-27 | Monash University | Treatment of T cell disorders |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20030032179A1 (en) | 2000-12-06 | 2003-02-13 | Hariri Robert J. | Post-partum mammalian placenta, its use and placental stem cells therefrom |
AU2002220209B2 (en) | 2000-12-06 | 2006-05-25 | Robert J. Hariri | Method of collecting placental stem cells |
WO2002081620A1 (en) * | 2001-04-03 | 2002-10-17 | Kabushiki Kaisya Advance | Three-dimensional cell culture systems |
US7129034B2 (en) * | 2001-10-25 | 2006-10-31 | Cedars-Sinai Medical Center | Differentiation of whole bone marrow |
CA2470853A1 (en) * | 2001-12-13 | 2003-06-19 | Japan Science And Technology Agency | Human cell culture medium and culture method |
EP1487463A2 (en) * | 2002-03-02 | 2004-12-22 | Board Of Regents The University Of Texas System | Local production and/or delivery of anti-cancer agents by stromal cell precursors |
US20040076617A1 (en) * | 2002-03-18 | 2004-04-22 | Lieber Jonathan Gregory | Method for production of neutrophils and uses therefor |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
DE60334453D1 (en) * | 2002-05-30 | 2010-11-18 | Macrogenics Inc | CD16A BINDING PROTEINS AND USE FOR THE TREATMENT OF IMMUNE DISEASES |
US7838290B2 (en) * | 2002-07-25 | 2010-11-23 | The Scripps Research Institute | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
KR101042448B1 (en) | 2002-11-26 | 2011-06-16 | 안트로제네시스 코포레이션 | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
NZ566132A (en) * | 2003-02-13 | 2009-09-25 | Anthrogenesis Corp | Use of umbilical cord blood to treat inflammation, ParkinsonÆs disease or diabetes |
US20050003533A1 (en) * | 2003-05-08 | 2005-01-06 | Pawel Kalinski | Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use |
US20050023085A1 (en) * | 2003-07-30 | 2005-02-03 | Munton Timothy John | Lifesaver apparatus |
US20080279812A1 (en) * | 2003-12-05 | 2008-11-13 | Norwood Immunology, Ltd. | Disease Prevention and Vaccination Prior to Thymic Reactivation |
DE602004028513D1 (en) | 2003-12-23 | 2010-09-16 | Mount Sinai Hospital Corp | PROCEDURE FOR DETECTING MARKERS ASSOCIATED WITH ENDOMETRIAL DISEASE OR PHASE |
US20070037276A1 (en) | 2004-02-23 | 2007-02-15 | Eudes Francois Marie De Crecy | Continuous culture apparatus with mobile vessel, allowing selection of fitter cell variants and producing a culture in a continuous manner |
JP5139799B2 (en) * | 2004-06-04 | 2013-02-06 | ユニベルシテ ピエール エ マリー キュリー(パリ シズエム) | Red blood cell production method |
EP1773981A1 (en) * | 2004-07-12 | 2007-04-18 | Sorin Group Italia S.R.L. | Device and method for growing human cells |
US20060035375A1 (en) * | 2004-08-16 | 2006-02-16 | Head Jonathan F | Method for selectively culturing epithelial or carcinoma cells |
US7989001B2 (en) * | 2004-09-13 | 2011-08-02 | Untae Kim | Method of separating tumor cells with and without lymphotropic metastatic potential in a human carcinoma |
DK1645626T3 (en) | 2004-09-30 | 2008-01-21 | Reneuron Ltd | cell Line |
US20080112933A1 (en) * | 2004-11-08 | 2008-05-15 | Scadden David T | Methods and Compositions for Increasing Stem Cell Homing Using Gas Activators |
US8071367B2 (en) | 2005-05-04 | 2011-12-06 | Commonwealth Scientific And Industrial Research Organisation | Selecting, culturing and creating lineage committed hematopoietic stem cells |
ES2452595T3 (en) | 2005-10-13 | 2014-04-02 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
CN101330830B (en) | 2005-10-18 | 2016-01-20 | 国家犹太健康中心 | Condition immortalization long-term stem cells and preparation and use the method for described cell |
JP2009517343A (en) * | 2005-11-14 | 2009-04-30 | エンタープライズ パートナーズ ベンチャー キャピタル | Stem cell factor therapy for tissue damage |
US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
KR20210122908A (en) | 2005-12-29 | 2021-10-12 | 안트로제네시스 코포레이션 | Placental stem cell populations |
AU2006332679A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
US7682822B2 (en) | 2006-03-31 | 2010-03-23 | Aastrom Biosciences, Inc. | Ex vivo generated tissue system |
WO2007146105A2 (en) * | 2006-06-05 | 2007-12-21 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
US20080050814A1 (en) * | 2006-06-05 | 2008-02-28 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
WO2007149493A2 (en) * | 2006-06-22 | 2007-12-27 | Immugen Inc | Restoration of hearing loss |
WO2008020654A2 (en) | 2006-08-18 | 2008-02-21 | Ajinomoto Co., Inc. | An l-glutamic acid producing bacterium and a method for producing l-glutamic acid |
EP2061871A1 (en) * | 2006-09-14 | 2009-05-27 | ProBioGen AG | Modular culture system for maintenance, differentiation and proliferation of cells |
CA2668330C (en) | 2006-11-03 | 2016-02-02 | Aastrom Biosciences, Inc. | Mixed cell populations for tissue repair and separation technique for cell processing |
WO2008097927A2 (en) * | 2007-02-06 | 2008-08-14 | Tai June Yoo | Treatment and prevention of neurodegenerative diseases using gene therapy |
EP2129775A1 (en) | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
DK2120977T3 (en) | 2007-02-12 | 2013-08-12 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
US7655216B2 (en) * | 2007-02-26 | 2010-02-02 | University of Pittsburgh - of the Commonwealth of Higher Education | Vaccine for activating helper function of CD8+ Tcells |
CA2678893C (en) * | 2007-03-05 | 2015-12-29 | Caridianbct, Inc. | Methods to control cell movement in hollow fiber bioreactors |
JP2010519937A (en) | 2007-03-05 | 2010-06-10 | カリディアンビーシーティー、インコーポレーテッド | Cell proliferation system and method of use |
WO2008124229A2 (en) * | 2007-04-06 | 2008-10-16 | Caridianbct, Inc. | Improved bioreactor surfaces |
WO2008128165A2 (en) * | 2007-04-13 | 2008-10-23 | Caridianbct, Inc. | Cell expansion system and methods of use |
KR20210022148A (en) | 2007-09-28 | 2021-03-02 | 안트로제네시스 코포레이션 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
EP2209810A1 (en) * | 2007-10-15 | 2010-07-28 | King's College London | Viral therapeutic |
US9527828B2 (en) * | 2007-12-06 | 2016-12-27 | Nissan Chemical Industries, Ltd. | Method for expanding hematopoietic stem cells using heterocyclic compound |
US10350243B2 (en) * | 2008-01-30 | 2019-07-16 | Memorial Sloan-Kettering Cancer Center | Methods for off-the-shelf-tumor immunotherapy using allogeneic T-cell precursors |
WO2009097140A1 (en) | 2008-01-30 | 2009-08-06 | Memorial Sloan-Kettering Cancer Center | Methods for off -the -shelf tumor immunotherapy using allogeneic t-cell precursors |
CA2618163A1 (en) | 2008-02-07 | 2009-08-07 | K. W. Michael Siu | Head and neck cancer biomarkers |
IL287311B1 (en) | 2008-05-16 | 2024-02-01 | Taiga Biotechnologies Inc | Antibodies and processes for preparing the same |
KR20110050521A (en) | 2008-08-20 | 2011-05-13 | 안트로제네시스 코포레이션 | Improved cell composition and methods of making the same |
KR101903049B1 (en) | 2008-08-20 | 2018-11-07 | 안트로제네시스 코포레이션 | Treatment of stroke using isolated placental cells |
KR20110050688A (en) | 2008-08-22 | 2011-05-16 | 안트로제네시스 코포레이션 | Methods and compositions for treatment of bone defects with placental cell populations |
IL301475A (en) | 2008-08-28 | 2023-05-01 | Taiga Biotechnologies Inc | In Vitro Methods for Increasing Viability of Immune-Cells |
US9107909B2 (en) * | 2008-11-06 | 2015-08-18 | Indiana University Research & Technology Corp. | Materials and methods to enhance hematopoietic stem cells engraftment procedures |
AU2009316541B2 (en) | 2008-11-19 | 2015-08-06 | Celularity Inc. | Amnion derived adherent cells |
EP2439204B1 (en) * | 2009-06-04 | 2017-01-04 | Nissan Chemical Industries, Ltd. | Heterocyclic compound and hematopoietic stem cell amplifier |
JP2011045269A (en) * | 2009-08-26 | 2011-03-10 | Hirosaki Univ | Method for culturing stem cell and/or precursor cell |
EP3284818B1 (en) | 2010-01-26 | 2022-03-09 | Celularity Inc. | Treatment of bone-related cancers using placental stem cells |
KR20230054905A (en) | 2010-04-07 | 2023-04-25 | 셀룰래리티 인코포레이티드 | Angiogenesis using placental stem cells |
WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
EP2566951B1 (en) | 2010-05-05 | 2020-03-04 | Terumo BCT, Inc. | Method of reseeding adherent cells grown in a hollow fiber bioreactor system |
ES2666746T3 (en) | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Methods to generate natural cytolytic lymphocytes |
US9040464B2 (en) | 2010-08-16 | 2015-05-26 | Mount Sinai Hosptial | Markers of the male urogenital tract |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
PL2714059T3 (en) | 2011-06-01 | 2019-04-30 | Celularity Inc | Treatment of pain using placental stem cells |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
DK3269802T3 (en) | 2011-09-30 | 2020-02-03 | Bluebird Bio Inc | RELATIONSHIPS FOR IMPROVED VIRUS TRANSDUCTION |
WO2013121426A1 (en) | 2012-02-13 | 2013-08-22 | Gamida-Cell Ltd. | Culturing of mesenchymal stem cells |
US8940294B2 (en) | 2012-03-02 | 2015-01-27 | Tissuetech, Inc. | Methods of isolating and culturing stem cells |
LT2846809T (en) | 2012-05-09 | 2021-01-25 | Cantex Pharmaceuticals, Inc. | Treatment of myelosuppression |
EP2872154B1 (en) * | 2012-07-11 | 2017-05-31 | Sangamo BioSciences, Inc. | Methods and compositions for delivery of biologics |
CA2879667C (en) | 2012-07-20 | 2021-11-16 | Taiga Biotechnologies, Inc. | Enhanced reconstitution and autoreconstitution of the hematopoietic compartment comprising a myc polypeptide |
US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
US9175259B2 (en) | 2012-08-20 | 2015-11-03 | Terumo Bct, Inc. | Method of loading and distributing cells in a bioreactor of a cell expansion system |
US9763983B2 (en) | 2013-02-05 | 2017-09-19 | Anthrogenesis Corporation | Natural killer cells from placenta |
US10272115B2 (en) | 2013-03-11 | 2019-04-30 | Taiga Biotechnologies, Inc. | Production and use of red blood cells |
US9365825B2 (en) | 2013-03-11 | 2016-06-14 | Taiga Biotechnologies, Inc. | Expansion of adult stem cells in vitro |
WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
WO2015164808A1 (en) | 2014-04-24 | 2015-10-29 | Terumo Bct, Inc. | Measuring flow rate |
CN106715676A (en) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | Scheduled feed |
US20160243168A1 (en) * | 2015-02-17 | 2016-08-25 | Cantex Pharmaceuticals, Inc. | Adoptive cell transfer methods |
EP3258941A4 (en) | 2015-02-17 | 2018-09-26 | Cantex Pharmaceuticals, Inc. | Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction |
US11725179B2 (en) | 2015-05-12 | 2023-08-15 | On-Chip Biotechnologies Co., Ltd. | Single-particle analysis method, and system for performing said analysis |
GB201508752D0 (en) | 2015-05-21 | 2015-07-01 | Mason Christopher And Veraitch Farlan S | Cell culture device, system and methods of use thereof |
US10669516B2 (en) * | 2015-06-23 | 2020-06-02 | The Board Of Regents Of The University Of Texas System | Methods and apparatus for conditioning cell populations for cell therapies |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US11286454B2 (en) | 2015-08-31 | 2022-03-29 | I Peace, Inc. | Pluripotent stem cell manufacturing system and method for producing induced pluripotent stem cells |
JPWO2017061528A1 (en) * | 2015-10-09 | 2018-07-26 | 国立大学法人名古屋大学 | Platelet manufacturing device, platelet manufacturing apparatus and platelet manufacturing method |
EP3413896B1 (en) | 2016-02-12 | 2021-03-17 | Bluebird Bio, Inc. | Vcn enhancer compositions and methods of using the same |
WO2017169259A1 (en) * | 2016-03-28 | 2017-10-05 | ソニー株式会社 | Cell culture container, cell culture system, cell culture kit and cell culture method |
JP6111510B1 (en) | 2016-05-02 | 2017-04-12 | インテグリカルチャー株式会社 | Growth induction system, growth induction control device, growth induction control method, and growth induction control program |
KR102170373B1 (en) | 2016-05-02 | 2020-10-27 | 인테그리컬쳐 인코포레이티드 | Growth induction system, growth induction control device, growth induction control method, and growth induction control program |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
EP4242298A2 (en) | 2016-12-02 | 2023-09-13 | Taiga Biotechnologies, Inc. | Nanoparticle formulations |
US11702634B2 (en) | 2017-03-31 | 2023-07-18 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
US10149898B2 (en) | 2017-08-03 | 2018-12-11 | Taiga Biotechnologies, Inc. | Methods and compositions for the treatment of melanoma |
CN112004919A (en) * | 2018-03-30 | 2020-11-27 | 帝斯曼知识产权资产管理有限公司 | Method for reducing emulsions by broth washing |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486188A (en) * | 1980-08-14 | 1984-12-04 | Applied Medical Devices, Inc. | Bone marrow transplant method and apparatus |
US4481946A (en) * | 1980-08-14 | 1984-11-13 | Altshuler John H | Bone marrow transplant method and apparatus |
US4514499A (en) * | 1983-02-04 | 1985-04-30 | Corning Glass Works | Cell culture using a monolithic support |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5032407A (en) * | 1987-01-16 | 1991-07-16 | Ohio University Edison Animal Biotechnology Center | Gene transfer using transformed, neodetermined, embryonic cells |
EP0753574A1 (en) * | 1989-06-15 | 1997-01-15 | The Regents of The University of Michigan | Methods and compositions for obtaining ex vivo human progenitor cell expansion |
US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
NL9101680A (en) * | 1991-10-04 | 1993-05-03 | Tno | METHOD FOR GENETICALLY MODIFYING PRIMATE BONE MARROW CELLS AND USE CELLS PRODUCING RECOMBINANT RETROVIRAL VECTORS. |
CA2131368A1 (en) * | 1992-03-04 | 1993-09-16 | Chu-Chih Shih | Culturing of hematopoietic stem cells and their genetic engineering |
WO1993018136A1 (en) * | 1992-03-05 | 1993-09-16 | Cytomed, Inc. | Process for supporting hematopoietic progenitor cells |
WO1995006409A1 (en) * | 1993-09-03 | 1995-03-09 | Systemix, Inc. | Genetically modified human hematopoietic stem cells and their progeny |
-
1991
- 1991-08-05 US US07/740,590 patent/US5399493A/en not_active Expired - Lifetime
- 1991-12-17 CA CA002100268A patent/CA2100268C/en not_active Expired - Lifetime
- 1991-12-17 EP EP04101846A patent/EP1473360A3/en not_active Withdrawn
- 1991-12-17 DE DE69133459T patent/DE69133459T2/en not_active Expired - Lifetime
- 1991-12-17 EP EP92904136A patent/EP0575350B1/en not_active Expired - Lifetime
- 1991-12-17 WO PCT/US1991/009173 patent/WO1992011355A1/en active IP Right Grant
- 1991-12-17 AT AT92904136T patent/ATE295412T1/en not_active IP Right Cessation
- 1991-12-17 JP JP4504303A patent/JPH06505151A/en active Pending
- 1991-12-17 KR KR1019930701843A patent/KR100225307B1/en not_active IP Right Cessation
-
1994
- 1994-12-30 US US08/366,493 patent/US5670351A/en not_active Expired - Lifetime
-
1996
- 1996-04-10 AU AU50592/96A patent/AU687674B2/en not_active Ceased
-
1998
- 1998-12-02 JP JP10342917A patent/JPH11221074A/en active Pending
-
2000
- 2000-01-26 JP JP2000017257A patent/JP2000189157A/en active Pending
- 2000-09-26 JP JP2000291494A patent/JP2001120261A/en active Pending
-
2006
- 2006-01-05 JP JP2006000956A patent/JP2006158401A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR100225307B1 (en) | 1999-10-15 |
DE69133459D1 (en) | 2005-06-16 |
EP1473360A2 (en) | 2004-11-03 |
JP2000189157A (en) | 2000-07-11 |
JPH11221074A (en) | 1999-08-17 |
JP2006158401A (en) | 2006-06-22 |
EP1473360A3 (en) | 2005-02-02 |
JP2001120261A (en) | 2001-05-08 |
JPH06505151A (en) | 1994-06-16 |
AU5059296A (en) | 1996-07-11 |
EP0575350A4 (en) | 1997-07-02 |
US5670351A (en) | 1997-09-23 |
DE69133459T2 (en) | 2006-01-19 |
KR930703434A (en) | 1993-11-30 |
EP0575350B1 (en) | 2005-05-11 |
EP0575350A1 (en) | 1993-12-29 |
ATE295412T1 (en) | 2005-05-15 |
AU687674B2 (en) | 1998-02-26 |
AU665525B2 (en) | 1996-01-11 |
US5399493A (en) | 1995-03-21 |
EP1473360A8 (en) | 2010-07-28 |
CA2100268C (en) | 2008-12-02 |
AU9175091A (en) | 1992-07-22 |
WO1992011355A1 (en) | 1992-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2100268A1 (en) | Method for culturing and transforming human stem cell-containing compositions | |
EA199800835A1 (en) | Culture medium of mammalian cells, process for its preparation and a mixture of components, compositions, methods of preparation, production of clonal growth, reproduction and altered phenotype of hepatocytes IN VITRO, CELLS, PHARMACEUTICAL COMPOSITION AND METHODS FOR recombinant cells and gene product, by use of cells, a method of transplanting hepatocytes , METHOD FOR TESTING A MEDICAL PREPARATION, METHOD FOR MAINTAINING THE VIABILITY OF DIFFERENTIATED HEPATOCYTES | |
RS50330B (en) | Process for culturing cells in a monolayer | |
WO1990015877A3 (en) | Methods, compositions and devices for growing cells | |
CA2122141A1 (en) | Methods for selectively expanding stem cells | |
CA2131385A1 (en) | Methods, compositions and devices for maintaining and growing human stem or hematopoietic cells | |
CS188392A3 (en) | Process for preparing protoplasm and/or fermentation products understerile conditions and apparatus for making the same | |
Saunders et al. | Shoot regeneration from hormone-autonomous callus from shoot cultures of several sugarbeet (Beta vulgaris L.) genotypes | |
CN108486050A (en) | The method for preparing mescenchymal stem cell from the umbilical cord of dog | |
JPS603830B2 (en) | Methods for culturing plant cells in vitro | |
EP0282164A3 (en) | Method for plant tissue culture | |
NABESHIMA et al. | Production of tropane alkaloids by hairy root cultures of Scopolia japonica | |
RU93054771A (en) | CULTIVATION METHOD, CELL, BIOREACTOR, FIBROBLASTES, CELL SEPARATION METHOD | |
Sun et al. | Selective growth of some rodent epithelial cells in a medium containing citrulline. | |
JPS6410922A (en) | Formation of somatic cell germ of cacao and regeneration of plant | |
Emerson et al. | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures | |
Lazar et al. | Production of biologicals by animal cells immobilized in polyurethane foam matrix | |
EP0252617A3 (en) | Micropropagation process | |
CN213977735U (en) | Cartilage diaphragm autocrine factor retention culture dish | |
ABE et al. | Nuclear behavior of Rhodosporidium toruloides, a heterobasidiomycetous yeast | |
CN112210498A (en) | Cartilage diaphragm autocrine factor retention culture dish | |
Lindsey et al. | [36] Techniques for the immobilization of plant cells | |
Glassman et al. | Corneal endothelium: a modified method for cultivation | |
Dougall | Dilution Plating and Nutritional Considerations: B. Plant Cells | |
EP0276154A3 (en) | Method and apparatus for cell culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKEC | Expiry (correction) |
Effective date: 20121202 |